- 2020.8.24
- Patents, Articles & Conferences Ms. Yukari Ikeda will present data of skin penetration of our anti-IFNγ aptamer at the 36th Annual Meeting of the Japan Society of Drug Delivery System on August 28th 2020
- 2020.6.22
- Information We updated in-house pipeline
- 2020.6.1
- Information TAGCyx established an Audit & Supervisory Board
- 2020.5.28
- Information Notice of New management team
- 2020.5.26
- Patents, Articles & Conferences Patent “DNA aptamer capable of bonding to VWF” is granted in Japan.
- 2020.5.5
- News Release TAGCyx raises approximately 200 million JPY
- 2020.2.19
- News Release TAGCyx and GC Pharma has entered into collaborative research and development for conducting various pre-clinical studies of TAGX-0004
- 2019.12.25
- News Release TAGCyx receives milestone payment for collaborative research with HEALIOS K.K.
- 2019.10.10
- News Release TAGCyx enters into a collaborative aptamer glycosylation research agreement with GlyTech, Inc.
- 2019.10.9
- News Release TAGCyx has executed a collaborative antibody-aptamer conjugate research agreement with Chiome Bioscience Inc.
- 2019.9.19
- Event Aptamer Seminar in Tokyo will be held
- 2018.10.4
- Patents, Articles & Conferences Collaborator, Dr. Kazuya Sakai will present data of anti-von Willerbrand Factor A1 domain Xenoligo at the American Society of Hematology